Keyphrases
Academic Readiness
32%
Activated Protein C
32%
Acute Coronary Syndrome
32%
Adjusted R2
12%
Advanced Kidney Disease
32%
Albumin Permeability
32%
ANCA-associated
32%
Antibody-associated
32%
Antineutrophil Cytoplasmic Antibody
32%
Anuria
19%
Arteriovenous Fistula
22%
Bibliometric Study
32%
Cardiac Damage
19%
Cardiovascular Morbidity
12%
Cardiovascular Mortality
19%
Chest Pain
32%
Childhood Type 1 Diabetes
32%
Chronic Kidney Disease
13%
Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)
12%
Cockcroft-Gault
12%
Coronary Artery Disease
32%
Creatinine Clearance
32%
Cystatin C (Cys C)
22%
Dialysis Treatment
12%
Drug Responsiveness
32%
Editorial Process
32%
EGFR Equation
32%
Existing Equations
12%
Family Reputation
13%
Female Patients
32%
Ficoll
32%
Galectin-8
32%
Glomerular Capillary
16%
Glomerular Disease
32%
Glomerular Size
32%
Graft Failure
18%
History of Medical Education
16%
Hyperpermeability
32%
Idiopathic Membranous Nephropathy
32%
IgG2
17%
IgG4-related Disease (IgG4-RD)
14%
Improved Prediction
32%
Index-based
32%
Inhibitor Complex
32%
Initial Momentum
16%
Internal Validation
12%
International Society of Nephrology
32%
Journal Performance
16%
Journal Website
16%
Kidney Atlas
32%
Kidney Care
24%
Kidney Disease
32%
Large Vessel Vasculitis
32%
Libya
74%
Libyan
64%
Low-grade Albuminuria
24%
Madinah
32%
Malm
19%
MDRD Equation
12%
Medical Education
64%
Medical School
48%
Medical University
16%
Microscopic Polyangiitis
19%
Monocyte Chemoattractant protein-1 (MCP-1)
32%
Nephrologists
32%
Organ Damage
32%
Permeability Studies
32%
Persistent Vegetative State
32%
Plasma Creatinine
12%
Plasma-activated
32%
Point Prevalence Survey
12%
Polyarteritis Nodosa
19%
Protein C Inhibitor
32%
Publication Productivity
32%
Publication Rate
21%
Publishing Practices
16%
PubMed
32%
Ratio Adjustment
32%
Renal Care
32%
Renal Damage
12%
Renal Death
16%
Renal Survival
32%
Renal Vasculitis
32%
Selectivity Index
32%
Serum Cystatin C
32%
Socioeconomic Status
32%
Spouses
32%
Strong Predictor
32%
Triage Tool
32%
Tribal Society
32%
Tubular Injury
19%
Two-pore
32%
Type 2 Diabetic Nephropathy
32%
Unbound Fraction
12%
Urinary Albumin
12%
Urinary IgM
32%
Vascular Aging
32%
Vasculitis Damage Index
32%
Wegener's Granulomatosis
19%
Weighted Measure
19%
Pharmacology, Toxicology and Pharmaceutical Science
Activated Protein C
32%
Acute Coronary Syndrome
16%
Albuminuria
49%
Alpha-Linolenic Acid
25%
Angiotensin II
32%
Arteriovenous Fistula
22%
Autoantibodies
6%
Cardiovascular Mortality
20%
Chromium 51
6%
Chronic Disease
10%
Chronic Kidney Failure
10%
Coronary Artery Disease
32%
Creatinine
21%
Cystatin C
32%
Diabetes Mellitus
41%
Diabetic Nephropathy
72%
Disease Duration
6%
End Stage Renal Disease
46%
Enzyme-Linked Immunosorbent Assay
12%
Epidemic
32%
Experimental Diabetic Nephropathy
10%
Ficoll
42%
Galectin
11%
Galectin 8
32%
Glomerulonephritis
11%
Glomerulopathy
96%
Graft Failure
18%
Heart Injury
19%
Immunoglobulin M
100%
Infection
32%
Insulin Dependent Diabetes Mellitus
64%
Interleukin 8
6%
Kidney Disease
32%
Kidney Dysfunction
32%
Kidney Failure
42%
Membranous Glomerulonephritis
32%
Microscopic Polyangiitis
19%
Monocyte Chemotactic Protein 1
32%
Nephritis
6%
Nephrotic Syndrome
37%
Observational Study
9%
Pandemic
10%
Plasminogen Activator Inhibitor 3
32%
Polyarteritis nodosa
19%
Proliferative Glomerulonephritis
7%
Protein C
32%
Proteinuria
42%
Replacement Therapy
8%
Small Vessel Vasculitis
32%
Streptozotocin
10%
Survival Time
5%
Systemic Administration
8%
Systemic Vasculitis
6%
Thorax Pain
32%
Thrombomodulin
9%
Ureter Obstruction
32%
Vasculitis
32%
Wegener Granulomatosis
19%
Medicine and Dentistry
Adverse Event
6%
Albuminuria
41%
Autoantibodies
6%
Cardiovascular Mortality
13%
Cardiovascular System
38%
Chromium 51
6%
Chronic Kidney Disease
32%
Diabetes Mellitus
9%
Diabetic Nephropathy
32%
Disease Duration
6%
Disease Management
8%
End Stage Renal Disease
9%
Family Structure
32%
Ferritin
32%
Glomerular Filtration Barrier
8%
Glomerular Filtration Rate
13%
Glomerulonephritis
6%
Glomerulopathy
32%
Granulomatosis with Polyangiitis
19%
Health Care
24%
Health Care Cost
8%
Health System
16%
Heart Injury
19%
Immunoglobulin G2
9%
Immunoglobulin G4
7%
Immunoglobulin M
64%
Inflammatory Disorder
6%
Insulin Dependent Diabetes Mellitus
9%
Interleukin 6
6%
Interleukin 8
6%
Iron Overload
32%
Kidney Function
32%
Magnetic Resonance Imaging
7%
Membranous Glomerulonephritis
32%
Mesangial Proliferative Glomerulonephritis
7%
Microscopic Polyangiitis
19%
Model Selection
6%
Monocyte Chemotactic Protein 1
32%
Nephritic Syndrome
6%
Nephrologist
32%
Nephrology
32%
Nephropathy
16%
Nephrosclerosis
5%
Patient with Nephrotic Syndrome
12%
Patient with Type 1 Diabetes
32%
Persistent Vegetative State
32%
Polyarteritis nodosa
19%
Polygamy
10%
Predictive Marker
32%
Prophylaxis
8%
Renal Failure
36%
Renal Replacement Therapy
19%
Risk Stratification
6%
Small Vessel Vasculitis
32%
Spontaneously Hypertensive Rat
32%
Survival Time
5%
Systemic Administration
8%
Systemic Vasculitis
6%
Telemedicine
8%
Thalassemia
32%
Urinary Excretion
6%
Urinary System
22%
Vasculitis
32%
